Cargando…
Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy
PURPOSE: The design, conduct and completion of randomized trials for curative prostate cancer (PCa) treatments are challenging. To evaluate the effect of robot-assisted radical prostatectomy (RARP) versus focal irreversible electroporation (IRE) on patient-reported quality of life (QoL) and early on...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105143/ https://www.ncbi.nlm.nih.gov/pubmed/29594551 http://dx.doi.org/10.1007/s00345-018-2281-z |
_version_ | 1783349606301564928 |
---|---|
author | Scheltema, Matthijs J. Chang, John I. Böhm, Maret van den Bos, Willemien Blazevski, Alexandar Gielchinsky, Ilan Kalsbeek, Anton M. F. van Leeuwen, Pim J. Nguyen, Tuan V. de Reijke, Theo M. Siriwardana, Amila R. Thompson, James E. de la Rosette, Jean J. Stricker, Phillip D. |
author_facet | Scheltema, Matthijs J. Chang, John I. Böhm, Maret van den Bos, Willemien Blazevski, Alexandar Gielchinsky, Ilan Kalsbeek, Anton M. F. van Leeuwen, Pim J. Nguyen, Tuan V. de Reijke, Theo M. Siriwardana, Amila R. Thompson, James E. de la Rosette, Jean J. Stricker, Phillip D. |
author_sort | Scheltema, Matthijs J. |
collection | PubMed |
description | PURPOSE: The design, conduct and completion of randomized trials for curative prostate cancer (PCa) treatments are challenging. To evaluate the effect of robot-assisted radical prostatectomy (RARP) versus focal irreversible electroporation (IRE) on patient-reported quality of life (QoL) and early oncological control using propensity-scored matching. METHODS: Patients with T1c–cT2b significant PCa (high-volume ISUP 1 or any 2/3) who received unifocal IRE were pair-matched to patients who received nerve-sparing RARP. Patient-reported outcomes were prospectively assessed using the Expanded Prostate Cancer Index Composite (EPIC), AUA symptom score and Short Form of Health Survey (SF-12) physical and mental components. Oncological failure was defined as biochemical recurrence (RARP) or positive follow-up biopsies (IRE). Generalized mixed-effect models were used to compare IRE and RARP. RESULTS: 50 IRE patients were matched to 50 RARP patients by propensity score. IRE was significantly superior to RARP in preserving pad-free continence (UC) and erections sufficient for intercourse (ESI). The absolute differences were 44, 21, 13, 14% for UC and 32, 46, 27, 22% for ESI at 1.5, 3, 6, and 12 months, respectively. The EPIC summary scores showed no statistically significant differences. Urinary symptoms were reduced for IRE and RARP patients at 12 months, although IRE patient initially had more complaints. IRE patients experienced more early oncological failure than RARP patients. CONCLUSIONS: These data demonstrated the superior preservation of UC and ESI with IRE compared to RARP up to 12 months after treatment. Long-term oncological data are warranted to provide ultimate proof for or against focal therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00345-018-2281-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6105143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-61051432018-08-30 Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy Scheltema, Matthijs J. Chang, John I. Böhm, Maret van den Bos, Willemien Blazevski, Alexandar Gielchinsky, Ilan Kalsbeek, Anton M. F. van Leeuwen, Pim J. Nguyen, Tuan V. de Reijke, Theo M. Siriwardana, Amila R. Thompson, James E. de la Rosette, Jean J. Stricker, Phillip D. World J Urol Original Article PURPOSE: The design, conduct and completion of randomized trials for curative prostate cancer (PCa) treatments are challenging. To evaluate the effect of robot-assisted radical prostatectomy (RARP) versus focal irreversible electroporation (IRE) on patient-reported quality of life (QoL) and early oncological control using propensity-scored matching. METHODS: Patients with T1c–cT2b significant PCa (high-volume ISUP 1 or any 2/3) who received unifocal IRE were pair-matched to patients who received nerve-sparing RARP. Patient-reported outcomes were prospectively assessed using the Expanded Prostate Cancer Index Composite (EPIC), AUA symptom score and Short Form of Health Survey (SF-12) physical and mental components. Oncological failure was defined as biochemical recurrence (RARP) or positive follow-up biopsies (IRE). Generalized mixed-effect models were used to compare IRE and RARP. RESULTS: 50 IRE patients were matched to 50 RARP patients by propensity score. IRE was significantly superior to RARP in preserving pad-free continence (UC) and erections sufficient for intercourse (ESI). The absolute differences were 44, 21, 13, 14% for UC and 32, 46, 27, 22% for ESI at 1.5, 3, 6, and 12 months, respectively. The EPIC summary scores showed no statistically significant differences. Urinary symptoms were reduced for IRE and RARP patients at 12 months, although IRE patient initially had more complaints. IRE patients experienced more early oncological failure than RARP patients. CONCLUSIONS: These data demonstrated the superior preservation of UC and ESI with IRE compared to RARP up to 12 months after treatment. Long-term oncological data are warranted to provide ultimate proof for or against focal therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00345-018-2281-z) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-03-28 2018 /pmc/articles/PMC6105143/ /pubmed/29594551 http://dx.doi.org/10.1007/s00345-018-2281-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Scheltema, Matthijs J. Chang, John I. Böhm, Maret van den Bos, Willemien Blazevski, Alexandar Gielchinsky, Ilan Kalsbeek, Anton M. F. van Leeuwen, Pim J. Nguyen, Tuan V. de Reijke, Theo M. Siriwardana, Amila R. Thompson, James E. de la Rosette, Jean J. Stricker, Phillip D. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
title | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
title_full | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
title_fullStr | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
title_full_unstemmed | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
title_short | Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
title_sort | pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105143/ https://www.ncbi.nlm.nih.gov/pubmed/29594551 http://dx.doi.org/10.1007/s00345-018-2281-z |
work_keys_str_mv | AT scheltemamatthijsj pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT changjohni pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT bohmmaret pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT vandenboswillemien pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT blazevskialexandar pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT gielchinskyilan pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT kalsbeekantonmf pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT vanleeuwenpimj pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT nguyentuanv pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT dereijketheom pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT siriwardanaamilar pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT thompsonjamese pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT delarosettejeanj pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy AT strickerphillipd pairmatchedpatientreportedqualityoflifeandearlyoncologicalcontrolfollowingfocalirreversibleelectroporationversusrobotassistedradicalprostatectomy |